Tetrabenazine attenuates morphine-induced hyperlocomotion in mice

被引：0
|
作者：
Kitanaka, Junichi [1 ]
Kitanaka, Nobue [1 ]
Nakano, Tae [1 ]
Kandori, Takashi [1 ]
Muratani, Kazuki [1 ]
Murakami, Ayaka [1 ]
Tanaka, Koh-ichi [2 ]
Tomita, Kazuo [2 ,3 ]
Tsukahara, Takao [3 ]
Sato, Tomoaki [3 ]
Nishiyama, Nobuyoshi [2 ]
Takemura, Motohiko [1 ]
机构：
[1] Hyogo Coll Med, Dept Pharmacol, Nishinomiya, Hyogo, Japan
[2] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Div Pharmacol, Kobe, Hyogo, Japan
[3] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Appl Pharmacol, Kagoshima, Japan
来源：
JOURNAL OF PHARMACOLOGICAL SCIENCES | 2017年 / 133卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
2-P-34
引用
收藏
页码：S214 / S214
页数：1
相关论文
共 50 条
  • [1] Clorgyline inhibits morphine-induced hyperlocomotion, but not antinociception, in mice
    Kitanaka, Junichi
    Kitanaka, Nobue
    Tatsuta, Tomohiro
    Morita, Yoshio
    Takemura, Motohiko
    NEUROSCIENCE RESEARCH, 2006, 55 : S203 - S203
  • [2] THE ROLE OF DOPAMINE D(1)-RECEPTORS IN MORPHINE-INDUCED HYPERLOCOMOTION IN MICE
    FUNADA, M
    SUZUKI, T
    MISAWA, M
    NEUROSCIENCE LETTERS, 1994, 169 (1-2) : 1 - 4
  • [3] Tetrabenazine, a vesicular monoamine transporter-2 inhibitor, attenuates morphine-induced hyperlocomotion in mice through alteration of dopamine and 5-hydroxytryptamine turnover in the cerebral cortex
    Kitanaka, Nobue
    Kitanaka, Junichi
    Hall, F. Scott
    Kandori, Takashi
    Murakami, Ayaka
    Muratani, Kazuki
    Nakano, Tae
    Uhl, George R.
    Takemura, Motohiko
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2018, 172 : 9 - 16
  • [4] Effects of fluvoxamine on morphine-induced inhibition of gastrointestinal transit, antinociception and hyperlocomotion in mice
    Ise, Y
    Katayama, S
    Hirano, M
    Aoki, T
    Narita, M
    Suzuki, T
    NEUROSCIENCE LETTERS, 2001, 299 (1-2) : 29 - 32
  • [5] Chronic treatment of ethanol enhanced morphine-induced hyperlocomotion
    Andou, Kouji
    Shibasaki, Masahiro
    Tsuyuki, Tomohisa
    Otokozawa, Arni
    Mori, Tomohisa
    Suzuki, Tsutomu
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 : 227P - 227P
  • [6] Modification of morphine-induced hyperlocomotion and antinociception in mice by clorgyline, a monoamine oxidase-A inhibitor
    Kitanaka, Nobue
    Kitanaka, Junichi
    Takemura, Motohiko
    NEUROCHEMICAL RESEARCH, 2006, 31 (06) : 829 - 837
  • [7] Modification by clorgyline, a monoamine oxidase-A inhibitor, of morphine-induced hyperlocomotion and antinociception in mice
    Kitanaka, N
    Kitanaka, J
    Tatsuta, T
    Morita, Y
    Takemura, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2006, 100 : 251P - 251P
  • [8] Modification of Morphine-induced Hyperlocomotion and Antinociception in Mice by Clorgyline, a Monoamine Oxidase-A Inhibitor
    Nobue Kitanaka
    Junichi Kitanaka
    Motohiko Takemura
    Neurochemical Research, 2006, 31 : 829 - 837
  • [9] Is the nociceptin (NOP) receptor involved in attenuation of the expression of sensitization to morphine-induced hyperlocomotion in mice?
    Kotlinska, J
    Rafalski, P
    Talarek, S
    Dylag, T
    Rolka, K
    Wichmann, J
    Silberring, J
    BEHAVIOURAL PHARMACOLOGY, 2005, 16 (02): : 101 - 106
  • [10] Geranylgeranylacetone protects mice against morphine-induced hyperlocomotion, rewarding effect, and withdrawal syndrome
    Luo, Fu-Cheng
    Qi, Lei
    Lv, Tao
    Wang, Sheng-Dong
    Liu, Hua
    Nakamura, Hajime
    Yodoi, Junji
    Bai, Jie
    FREE RADICAL BIOLOGY AND MEDICINE, 2012, 52 (07) : 1218 - 1227
12345